The PTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The PTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View PTX Detailed Price Forecast - CNN Money||View PTX Detailed Summary - Google Finance|
|View PTX Detailed Summary - Yahoo! Finance||View PTX Stock Research & Analysis - Zacks.com|
|View PTX Trends & Analysis - Trade-Ideas||View PTX Major Holders - Barrons|
|View PTX Call Transcripts - NASDAQ||View PTX Breaking News & Analysis - Seeking Alpha|
|View PTX Annual Report - CompanySpotlight.com||View PTX OTC Short Report - OTCShortReport.com|
|View PTX Fundamentals - TradeKing||View PTX SEC Filings - Bar Chart|
|View Historical Prices for PTX - The WSJ||View Performance/Total Return for PTX - Morningstar|
|View the Analyst Estimates for PTX - MarketWatch||View the Earnings History for PTX - CNBC|
|View the PTX Earnings - StockMarketWatch||View PTX Buy or Sell Recommendations - MacroAxis|
|View the PTX Bullish Patterns - American Bulls||View PTX Short Pain Metrics - ShortPainBot.com|
|View PTX Stock Mentions - StockTwits||View PTX Stock Mentions - PennyStockTweets|
|View PTX Stock Mentions - Twitter||View PTX Investment Forum News - Investor Hub|
|View PTX Stock Mentions - Yahoo! Message Board||View PTX Stock Mentions - Seeking Alpha|
|View Insider Transactions for PTX - SECform4.com||View Insider Transactions for PTX - Insider Cow|
|View PTX Major Holdings Summary - CNBC||View Insider Disclosure for PTX - OTC Markets|
|View Insider Transactions for PTX - Yahoo! Finance||View Institutional Holdings for PTX - NASDAQ|
|View PTX Stock Insight & Charts - FinViz.com||View PTX Investment Charts - StockCharts.com|
|View PTX Stock Overview & Charts - BarChart||View PTX User Generated Charts - Trading View|
[$$] Drug Maker Pernix Therapeutics Files for Bankruptcy, Blaming Competition From Generics
Posted on Tuesday February 19, 2019
Holdings Inc., which makes painkiller Zohydro and other medications, has filed for bankruptcy protection after drug sales to consumers fell below expectations. It blamed a revenue drop partly on fresh competition with generic versions of its migraine treatment Treximet. In documents filed in U.S. Bankruptcy Court in Wilmington, Del., company officials said they already have a $76 million offer from affiliates of Highbridge Capital Management LLC, which offered to pay cash and forgive some of its debt.
Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management
Posted on Tuesday February 19, 2019
Pernix Therapeutics Holdings, Inc. (PTX) (“Pernix” or the “Company”), a holding company that owns several subsidiaries, including specialty pharmaceutical companies, today announced that it has entered into an Asset Purchase Agreement with certain funds managed by Highbridge Capital Management, LLC (collectively “Highbridge”). The Agreement serves as an initial “stalking-horse bid” to acquire substantially all of the assets of the Company and its subsidiaries, including the rights to all branded and generic products (the “Products”), for approximately $75.6 million in the form of cash and credit bid consideration. Pernix has also initiated voluntary proceedings under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware to undertake its restructuring and sale process.
Could The Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) Ownership Structure Tell Us Something Useful?
Posted on Saturday February 16, 2019
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Every investor in Pernix Therapeutics Holdings, Inc.Read More...
Analyst Reports Pernix Therapeutics Holdings, Inc. is Laying the Foundation for a Turnaround
Posted on Thursday February 14, 2019
NEW YORK, NY / ACCESSWIRE / February 14, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Pernix Therapeutics Holdings, Inc., (PTX) Pernix is the parent company of Pernix Therapeutics, LLC, a specialty pharmaceutical business focused on acquiring and commercializing prescription drugs, primarily for the U.S. market. During the third quarter, Contrave remained the leading prescription weight loss brand in the United States, and the company is currently exploring a number of initiatives to enhance the value of the brand globally. Pernix is extremely encouraged with the initial results from Contrave, which is the market-leading branded weight loss prescription drug.